marijuana stocks news

Form 8-K for LEXARIA BIOSCIENCE CORP.


7-Jun-2016

Regulation FD Disclosure, Financial Statements and Exhibits

Item 7.01 Regulation FD DisclosureA copy of the news release announcing our intention to complete an equity financing of CDN$100,000 is filed as exhibit 99.1 to this current report and is hereby incorporated by reference.

 

Item 9.01 Financial Statements and Exhibits99.1 Press Release dated May 31, 2016


– 2 –

 


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

$LXRP Looks to Validate Breakthrough Technology

Lexaria Looks to Validate Breakthrough Technology The medical cannabis industry has grown…

GrowGeneration Corp. (GRWG) Provides Full-Year 2023 Guidance Update Ahead of the 26th Annual ICR Conference

GrowGeneration Provides Full-Year 2023 Guidance Update Ahead of the 26th Annual ICR…

Tetra Bio-Pharma Inc. (TBPMF) Receives FDA Orphan Drug Designation for Hepatocellular Carcinoma

Tetra Bio-Pharma Receives FDA Orphan Drug Designation for Hepatocellular Carcinoma Tetra Bio-Pharma…

Lexaria Bioscience Corp. (LXRP) Announces Upcoming Investment Event and Warrant Exercise

Lexaria Bioscience Announces Upcoming Investment Event and Warrant Exercise Lexaria Bioscience Corp.…